WO2012021016A3 - Lactobacillus strain having anti-cancer activity and anti-cancer activity composition including same as active ingredient - Google Patents

Lactobacillus strain having anti-cancer activity and anti-cancer activity composition including same as active ingredient Download PDF

Info

Publication number
WO2012021016A3
WO2012021016A3 PCT/KR2011/005916 KR2011005916W WO2012021016A3 WO 2012021016 A3 WO2012021016 A3 WO 2012021016A3 KR 2011005916 W KR2011005916 W KR 2011005916W WO 2012021016 A3 WO2012021016 A3 WO 2012021016A3
Authority
WO
WIPO (PCT)
Prior art keywords
cancer activity
active ingredient
composition including
including same
lactobacillus
Prior art date
Application number
PCT/KR2011/005916
Other languages
French (fr)
Korean (ko)
Other versions
WO2012021016A2 (en
WO2012021016A9 (en
Inventor
박진형
박기범
김희정
Original Assignee
Park Jin Hyoung
Park Ki Beom
Kim Hee Jeong
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Park Jin Hyoung, Park Ki Beom, Kim Hee Jeong filed Critical Park Jin Hyoung
Publication of WO2012021016A2 publication Critical patent/WO2012021016A2/en
Publication of WO2012021016A3 publication Critical patent/WO2012021016A3/en
Publication of WO2012021016A9 publication Critical patent/WO2012021016A9/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/245—Lactobacillus casei

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

The present invention was conceived from the discovery of anti-cancer activity in lactobacillus out of many types of bacteria isolated while observing food-derived fermentation strains having the ability to ferment lactobacillus in apples, and provides lactobacillus casei (accession no. KCCM11072) having anti-cancer activity and the anti-cancer activity composition including same as an active ingredient, which can be used as a medical supply or as a health supplement food.
PCT/KR2011/005916 2010-08-12 2011-08-11 Lacobacillus strain having anti-cancer activity and anti-cancer activity composition including same as active ingredient WO2012021016A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2010-0077908 2010-08-12
KR1020100077908A KR20120015644A (en) 2010-08-12 2010-08-12 Lactobacillus having anticancer activity and composition comprising the lcatobacillus

Publications (3)

Publication Number Publication Date
WO2012021016A2 WO2012021016A2 (en) 2012-02-16
WO2012021016A3 true WO2012021016A3 (en) 2012-05-10
WO2012021016A9 WO2012021016A9 (en) 2012-06-28

Family

ID=45568066

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2011/005916 WO2012021016A2 (en) 2010-08-12 2011-08-11 Lacobacillus strain having anti-cancer activity and anti-cancer activity composition including same as active ingredient

Country Status (2)

Country Link
KR (1) KR20120015644A (en)
WO (1) WO2012021016A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101910808B1 (en) * 2016-11-28 2018-10-24 주식회사 쎌바이오텍 Protein P8 Derived from Lactic Acid Bacteria and Its Use as Anti-Caner Agent
KR102680587B1 (en) * 2018-05-28 2024-07-03 주식회사 쎌바이오텍 Active Fragment Peptide of Protein Derived from Lactic Acid Bacteria and Use of the Same
KR102457422B1 (en) * 2022-05-04 2022-10-21 주식회사 메디오젠 Composition for preventing or treating colorectal cancer comprising a mixed strain of probiotics
CN116948916B (en) * 2023-08-11 2024-06-11 四川大学 Lactobacillus casei and application thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000038058A (en) * 1998-12-03 2000-07-05 이은선 New lactobacillus casei ky 22713 which ferments mistletoe
WO2003045405A2 (en) * 2001-11-27 2003-06-05 Bio-K Plus International Inc. Lactic acid bacteria and their use for treating and preventing cancer
KR100411198B1 (en) * 2001-03-13 2003-12-18 매일유업주식회사 Formulation for inhibiting proliferation of tumor cell line
KR20100008831A (en) * 2008-07-17 2010-01-27 주식회사 쎌바이오텍 Anti-cancer composition comprising a culture fluid of lactobacillus casei as an effective component

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000038058A (en) * 1998-12-03 2000-07-05 이은선 New lactobacillus casei ky 22713 which ferments mistletoe
KR100411198B1 (en) * 2001-03-13 2003-12-18 매일유업주식회사 Formulation for inhibiting proliferation of tumor cell line
WO2003045405A2 (en) * 2001-11-27 2003-06-05 Bio-K Plus International Inc. Lactic acid bacteria and their use for treating and preventing cancer
KR20100008831A (en) * 2008-07-17 2010-01-27 주식회사 쎌바이오텍 Anti-cancer composition comprising a culture fluid of lactobacillus casei as an effective component

Also Published As

Publication number Publication date
KR20120015644A (en) 2012-02-22
WO2012021016A2 (en) 2012-02-16
WO2012021016A9 (en) 2012-06-28

Similar Documents

Publication Publication Date Title
MY172363A (en) Lipid metabolism and/or sugar metabolism improver containing lactic acid bacterium or treatment product thereof
EP4257194A3 (en) Use of microbial communities for human and animal health
WO2009138091A3 (en) Isolated microorganism strain lactobacillus plantarum tensia dsm 21380 as antimicrobial and antihypertensive probiotic, food product and composition comprising said microorganism and use of said microorganism for preparation of antihypertensive medicine and method for suppressing pathogens and non-starter lactobacilli in food product
UA46234U (en) Composition of ingredients of bread kvass
RU2013153578A (en) POLYBACTERIAL DRUG WITH ADVANTAGES FOR HEALTH: WITH ANTIOXIDANT EFFECT, REDUCED CONCENTRATION OF CHOLESTEROL, ANTI-INFLAMMATIVE EFFECT AND SUSTAINABILITY
WO2009142472A3 (en) Bifidobacteria that produces folic acid, food composition and use of said bifidobacteria
MX355955B (en) Synergistic antimicrobial effect.
TW200700074A (en) Inducer of t cell apoptosis
RU2010147343A (en) ISOLATED microorganism strain Lactobacillus plantarum Inducia DSM 21379 as probiotics, strengthens Innate immunity of the body, products, and compositions containing UPOMOMYANUTY microorganisms, and the use of said microorganisms for the preparation of a medicament that enhances the Cellular immunity
WO2009013709A3 (en) Zinc-enriched biomass, method for the preparation thereof and pro-biotic, cosmetic, dietary and nutraceutic products comprising the same
IN2012DN01638A (en)
EP1812023B8 (en) Lactic acid bacteria as probiotic strains and compositions containing same
ATE551419T1 (en) BACTERIAL STRAIN WITH ANTIALLERGIC ACTIVITY AND DRINK, FOOD AND ANTIALLERGIC DRUG WITH CELL OF THE BACTERIA STRAIN
GB0513556D0 (en) Product
MX2013004343A (en) Texturizing lactic acid bacteria strains.
MX2010005453A (en) Lactic acid bacterium-containing preparation.
WO2011162523A3 (en) Composition for preventing or treating osteoporosis, containing ssangwhatang or lactobacillus fermented product thereof
MX339951B (en) Bacillus subtilis isolate from corn.
MX337716B (en) Lactic acid bacterium-containing preparation.
CA2567976A1 (en) A composition having immunoregulating activities comprising lactobacillus pentosus
IN2012DN02283A (en)
WO2006119780A3 (en) New antibiotic-sensitive lactic acid bacteria strains
MX2012007970A (en) Process for the preparation of a biomass comprising plantaricin and uses thereof in medical field.
WO2012021016A3 (en) Lactobacillus strain having anti-cancer activity and anti-cancer activity composition including same as active ingredient
WO2011031145A3 (en) Improved soy milk fermentation

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11816632

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11816632

Country of ref document: EP

Kind code of ref document: A2